Cidara Therapeutics, Inc. Gains 105.41%
Fri, Nov 14, 2025 at 07:14 PM
Cidara Therapeutics, Inc. (CDTX:NASDAQ) rocketted at $217.71, representing a gain of 105.4%. On Fri, Nov 14, 2025, CDTX:NASDAQ touched a New 2-Week High of $217.71. The stock appeared on our News Catalysts scanner on Fri, Nov 14, 2025 at 06:51 PM in the 'BIOTECH' category. From Fri, Oct 31, 2025, the stock recorded 40.00% Up Days and 54.55% Green Days
About Cidara Therapeutics, Inc. (CDTX:NASDAQ)
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, CloudbreakTM.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 105.41%
- Cypherpunk Technologies Inc Com (New) (CYPH:NASDAQ), 56.25%
- Cycurion, Inc. (CYCU:NASDAQ), 51.2%
- Invivyd, Inc. (IVVD:NASDAQ), 32.77%
- The Oncology Institute, Inc. (TOI:NASDAQ), 28.9%
- NOMADAR Corp. (NOMA:NASDAQ), 26.46%
- Connect Biopharma Holdings Limited (CNTB:NASDAQ), 26.19%
- Precigen, Inc. (PGEN:NASDAQ), 25.65%
- Omeros Corporation (OMER:NASDAQ), 25.32%